NO890607D0 - Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater.Info
- Publication number
- NO890607D0 NO890607D0 NO890607A NO890607A NO890607D0 NO 890607 D0 NO890607 D0 NO 890607D0 NO 890607 A NO890607 A NO 890607A NO 890607 A NO890607 A NO 890607A NO 890607 D0 NO890607 D0 NO 890607D0
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- pyridine derivatives
- therapeutic active
- active pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888803516A GB8803516D0 (en) | 1988-02-16 | 1988-02-16 | Heterocyclic compounds |
GB888824666A GB8824666D0 (en) | 1988-10-21 | 1988-10-21 | Pyridine derivatives |
Publications (4)
Publication Number | Publication Date |
---|---|
NO890607D0 true NO890607D0 (no) | 1989-02-13 |
NO890607L NO890607L (no) | 1989-08-17 |
NO172491B NO172491B (no) | 1993-04-19 |
NO172491C NO172491C (no) | 1993-07-28 |
Family
ID=26293498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO890607A NO172491C (no) | 1988-02-16 | 1989-02-13 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater |
Country Status (24)
Country | Link |
---|---|
US (1) | US5166213A (no) |
EP (1) | EP0329360B1 (no) |
JP (1) | JP2812697B2 (no) |
KR (1) | KR0145725B1 (no) |
CN (1) | CN1040753C (no) |
AR (1) | AR246965A1 (no) |
AT (1) | ATE109478T1 (no) |
AU (1) | AU626534B2 (no) |
CA (1) | CA1335816C (no) |
DE (1) | DE68917170T2 (no) |
DK (1) | DK66989A (no) |
ES (1) | ES2057104T3 (no) |
FI (1) | FI93216C (no) |
GB (1) | GB8901201D0 (no) |
HU (1) | HU209700B (no) |
IE (1) | IE63825B1 (no) |
IL (1) | IL89214A (no) |
MY (1) | MY103699A (no) |
NO (1) | NO172491C (no) |
NZ (1) | NZ227880A (no) |
PH (1) | PH26227A (no) |
PL (1) | PL158201B1 (no) |
PT (1) | PT89703B (no) |
ZW (1) | ZW1789A1 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8709794D0 (en) * | 1987-04-24 | 1987-05-28 | Ici Plc | Heterocyclic acids |
IE81170B1 (en) * | 1988-10-21 | 2000-05-31 | Zeneca Ltd | Pyridine derivatives |
GB9021571D0 (en) * | 1990-10-04 | 1990-11-21 | Ici Plc | Heterocyclic acids |
PL1976509T3 (pl) * | 2006-01-18 | 2015-07-31 | Evolva Sa | Modulatory PPAR |
JP2010516702A (ja) * | 2007-01-18 | 2010-05-20 | エヴォルヴァ エスアー | 置換1,3−ジオキサンのプロドラッグおよびそれらの使用 |
AU2008206049A1 (en) | 2007-01-18 | 2008-07-24 | Evolva Sa | Substituted 1,3-dioxanes and their uses |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3262096D1 (en) * | 1981-03-30 | 1985-03-14 | Hoffmann La Roche | 1,3-dioxolane derivatives, their preparation, fungicidal agents containing those compounds as active agents and use of such compounds or agents in combating fungi in agriculture and in gardening |
GB8310407D0 (en) * | 1982-05-12 | 1983-05-25 | Ici Plc | 1 3 - dioxan -5- ylalkenoic acids |
GB8330094D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Diphenyl compounds |
GB8330120D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Chemical process |
GB8330099D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Cycloalkane derivatives |
US4554011A (en) * | 1984-08-24 | 1985-11-19 | Chevron Research Company | Herbicidal 2S-(2β,4β,5β)-5-Arylmethoxy-4-substituted 2-alkyl-1,3-dioxane derivatives |
GB8511894D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Phenol derivatives |
GB8511892D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Fluoralkane derivatives |
GB8511895D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Heterocyclic compounds |
GB8511890D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Benzene derivatives |
DK212786A (da) * | 1985-05-10 | 1986-11-11 | Ici Plc | 1,3-dioxanethere |
GB8511891D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Alkenoic acids |
DE3685775T2 (de) * | 1985-05-10 | 1993-01-21 | Ici Plc | Alkenderivate. |
WO1987002983A1 (en) * | 1985-11-12 | 1987-05-21 | Imperial Chemical Industries Plc | Amide derivatives |
GB8611174D0 (en) * | 1986-05-08 | 1986-06-18 | Ici Plc | Amide derivatives |
GB8531892D0 (en) * | 1985-12-30 | 1986-02-05 | Ici Plc | Carboxylic acids |
GB8626297D0 (en) * | 1986-11-04 | 1986-12-03 | Ici Plc | Pharmaceutical compositions |
GB8626296D0 (en) * | 1986-11-04 | 1986-12-03 | Ici Plc | Therapeutic agents |
GB8709794D0 (en) * | 1987-04-24 | 1987-05-28 | Ici Plc | Heterocyclic acids |
IE81170B1 (en) * | 1988-10-21 | 2000-05-31 | Zeneca Ltd | Pyridine derivatives |
-
1989
- 1989-01-19 GB GB898901201A patent/GB8901201D0/en active Pending
- 1989-02-07 IE IE39289A patent/IE63825B1/en not_active IP Right Cessation
- 1989-02-07 NZ NZ227880A patent/NZ227880A/xx unknown
- 1989-02-07 IL IL8921489A patent/IL89214A/en not_active IP Right Cessation
- 1989-02-08 CA CA000590484A patent/CA1335816C/en not_active Expired - Fee Related
- 1989-02-13 PT PT89703A patent/PT89703B/pt active IP Right Grant
- 1989-02-13 ZW ZW17/89A patent/ZW1789A1/xx unknown
- 1989-02-13 EP EP89301334A patent/EP0329360B1/en not_active Expired - Lifetime
- 1989-02-13 AT AT89301334T patent/ATE109478T1/de not_active IP Right Cessation
- 1989-02-13 AU AU29908/89A patent/AU626534B2/en not_active Ceased
- 1989-02-13 NO NO890607A patent/NO172491C/no unknown
- 1989-02-13 KR KR1019890001661A patent/KR0145725B1/ko not_active IP Right Cessation
- 1989-02-13 DK DK066989A patent/DK66989A/da not_active Application Discontinuation
- 1989-02-13 DE DE68917170T patent/DE68917170T2/de not_active Expired - Fee Related
- 1989-02-13 CN CN89100858A patent/CN1040753C/zh not_active Expired - Fee Related
- 1989-02-13 JP JP1031263A patent/JP2812697B2/ja not_active Expired - Lifetime
- 1989-02-13 PH PH38187A patent/PH26227A/en unknown
- 1989-02-13 HU HU89632A patent/HU209700B/hu not_active IP Right Cessation
- 1989-02-13 PL PL1989277709A patent/PL158201B1/pl unknown
- 1989-02-13 FI FI890678A patent/FI93216C/fi not_active IP Right Cessation
- 1989-02-13 ES ES89301334T patent/ES2057104T3/es not_active Expired - Lifetime
- 1989-02-14 AR AR89313211A patent/AR246965A1/es active
- 1989-02-14 US US07/310,235 patent/US5166213A/en not_active Expired - Fee Related
- 1989-02-16 MY MYPI89000189A patent/MY103699A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO894630L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
NO883974D0 (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
NO904694L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
NO871266D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO901684D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
NO870526L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
NO874032D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
NO883122L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
NO875488L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
NO166130C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater. | |
NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
NO891723L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO884176D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater. | |
NO895220D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzenderivater. | |
NO884175D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
NO864101D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
NO890607D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater. | |
NO900972L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
NO871907D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater. | |
NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
NO890724L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. | |
NO852563L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater. | |
NO882201D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater. |